CYCN vs GILD: Which Stock is Better?
Side-by-side comparison of Cyclerion Therapeutics Inc and Gilead Sciences Inc in 2026
CYCN
Cyclerion Therapeutics Inc
$1.35
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | CYCN | GILD | Winner |
|---|---|---|---|
| Market Cap | $5.14M | $154.03B | GILD |
| P/E Ratio | N/A | 19.22 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | 3.5% | 0.0% | CYCN |
| Gross Margin | 92.6% | 78.7% | CYCN |
Analyze CYCN
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CYCN or GILD a better investment?
Comparing CYCN and GILD: Cyclerion Therapeutics Inc has a market cap of $5.14M while Gilead Sciences Inc has $154.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CYCN and GILD?
CYCN (Cyclerion Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CYCN or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CYCN or GILD?
CYCN has higher revenue growth at 3.5% vs 0.0% for GILD.
Which company is more profitable: CYCN or GILD?
Cyclerion Therapeutics Inc (CYCN) has higher gross margins at 92.6% compared to 78.7% for GILD.
Which is the larger company: CYCN or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.03B compared to $5.14M for CYCN.
Should I buy CYCN or GILD in 2026?
Both CYCN and GILD have investment merit. CYCN trades at $1.35 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CYCN and GILD stock?
Key differences: Market Cap ($5.14M vs $154.03B), P/E Ratio (N/A vs 19.2x), Revenue Growth (3.5% vs 0.0%), Gross Margin (92.6% vs 78.7%).